To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis.

Inclusion Criteria:

• Sexually active women between 18 and 50 years
• Patients attending to the gynecologist with acute vulvovaginal candidiasis.
• Patients requiring standard treatment with clotrimazole 500 single dose and that the decision to prescribe this treatment is prior to inclusion in the study.
• Women who agree to participate in the study and has signed the informed consent sheet.

Exclusion Criteria:

• Use of any medication that may interfere significantly with study assessments.
• Pregnant or breastfeeding
• Women with signs of other genital infection
• Within 3 months after childbirth or abortion
• Patients that is expected not to attend follow-up visits